THE OBESITY REVOLUTION A new generation of obesity drugs is transforming patients’ lives, dividing medical experts, and spurring the biggest business battle in years. Known as GLP-1-based drugs, this medication class could have the medical and societal impact of blockbuste…

https://www.statnews.com/category/the-obesity-revolution/?utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz-8GIuqTfDCs8IhICvVtUJjh6GbLp7fYjOkKm8z8qXE_rD7L-3wbJfvcsBIrMwwhS0klvZDeMumN5QczIUUVlyJSlg01yw&_hsmi=312829735&utm_content=312829735&utm_source=hs_email The Aspen Ideas: Health conference took place this weekend, bringing together leaders from around the world. STAT’s Usha Lee McFarling was there and brings us these tidbits: Of course, no health conference these days is complete without talking about weight loss drugs. Rep. Larry Bucshon (R-Ind.), also a cardiothoracic surgeon, asked if there was data showing long-term health benefits that could curb health care costs and thus convince Congress to push for the expensive drugs to be paid for by CMS, which private insurers would likely follow. “I think these are the most important studies for us to do right now,” said panelist and cardiologist Harlan Krumholz. New studies suggest GLP-1 health care costs have only begun to climb Elaine Chen By Elaine Chen April 24, 2024 https://www.statnews.com/2024/04/24/weight-loss-drugs-to-drive-health-care-spending-reports-show/?utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz--QjEy7vBm6OuIarTmYDKJpHhzoHVchvcEzb-C-TDOiO8rT3H2jhGPXy0T3ZSnkcjtjVJxcRjrA_B_oqi7g5EvvC8LQVw&_hsmi=312829735&utm_content=312829735&utm_source=hs_email